FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Merrill Kies

Research Profile

Disorders

Procedures

Concepts & Ideas

Chemicals & Drugs

Co-author Network

Publications

TOP 3
Lai-ping Zhong; Han-guang Zhu; Yi-li Cai; Xin-dong Fan; Wei Guo; Yue He; Yong-jie Hu; Tong Ji; Merrill S Kies; J Jack Lee; Jun Li; Jiang Li; Jeffrey N Myers; Guo-xin Ren; Jian Sun; Wen-yong Tu; Bo-song Wang; Li-zhen Wang; Yan-an Wang; Zhong-he Wang; William N William; Li-qun Xu; Wen-jun Yang; Wei-min Ye; Chen-ping Zhang; Zhi-yuan Zhang
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Adam S Garden; Bonnie S Glisson; Gary B Gunn; Merrill S Kies; William H Morrison; David I Rosenthal; K. Kian Ang; Beth M Beadle; Steven J Frank; Randal S Weber; Erich M Sturgis
Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.
Tarek El-Sawy; Bonnie S Glisson; Merrill S Kies; Scott Lippman; Jeffrey N Myers; Anita L Sabichi; William N William; Bita Esmaeli
Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Merrill Kies (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: Lai-ping Zhong; Han-guang Zhu; Yi-li Cai; Xin-dong Fan; Wei Guo; Yue He; Yong-jie Hu; Tong Ji; Merrill S Kies; J Jack Lee; Jun Li; Jiang Li; Jeffrey N Myers; Guo-xin Ren; Jian Sun; Wen-yong Tu; Bo-song Wang; Li-zhen Wang; Yan-an Wang; Zhong-he Wang; William N William; Li-qun Xu; Wen-jun Yang; Wei-min Ye; Chen-ping Zhang; Zhi-yuan Zhang
Randomized phase III trial of induction chemotherapy with docetaxel, cisplatin, and fluorouracil followed by surgery versus up-front surgery in locally advanced resectable oral squamous cell carcinoma.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2013;31(6):744-51.
2013: Adam S Garden; Bonnie S Glisson; Gary B Gunn; Merrill S Kies; William H Morrison; David I Rosenthal; K. Kian Ang; Beth M Beadle; Steven J Frank; Randal S Weber; Erich M Sturgis
Outcomes and patterns of care of patients with locally advanced oropharyngeal carcinoma treated in the early 21st century.
Radiation oncology (London, England) 2013;8():21.
2012: Tarek El-Sawy; Bonnie S Glisson; Merrill S Kies; Scott Lippman; Jeffrey N Myers; Anita L Sabichi; William N William; Bita Esmaeli
Epidermal growth factor receptor inhibitors for treatment of orbital squamous cell carcinoma.
Archives of ophthalmology 2012;130(12):1608-11.
2012: Samant Sandeep; Michiel W van den Brekel; Jim Wan; Merrill S Kies; Coen Rasch; K Thomas Robbins; David I Rosenthal; Randal S Weber
Concurrent chemoradiation for adenoid cystic carcinoma of the head and neck.
Head & neck 2012;34(9):1263-8.
2012: Merrill S Kies; Jan S Lewin; Guojun Li; Ganene D Steinhaus; George Blumenschein; Dowin H Boatright; G Brandon Gunn; Adel K El-Naggar; Erich M Sturgis
Phase II trial of induction chemotherapy followed by surgery for squamous cell carcinoma of the oral tongue in young adults.
Head & neck 2012;34(9):1255-62.
2012: Catherine H McHugh; Dianna B Roberts; Randal S Weber; Adel K El-Naggar; Adam S Garden; Ehab Y Hanna; Merrill S Kies; Michael E Kupferman
Prognostic factors in mucoepidermoid carcinoma of the salivary glands.
Cancer 2012;118(16):3928-36.
2011: Anne S Tsao; Ignacio I Wistuba; Hai T Tran; George R Blumenschein; Chusilp Charnsangavej; Frank V Fossella; Junya Fujimoto; Waun K Hong; Merrill S Kies; J Jack Lee; Suyu Liu; Edith M Marom; Vassiliki A Papadimitrakopoulou; David J Stewart
Phase II trials of imatinib mesylate and docetaxel in patients with metastatic non-small cell lung cancer and head and neck squamous cell carcinoma.
Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer 2011;6(12):2104-11.
2011: Edward S Kim; J Jack Lee; Scott M Lippman; Suyu Liu; Li Mao; Vassiliki Papadimitrakopoulou; David J Stewart; Ximing Tang; Hai T Tran; Anne Tsao; Ignacio I Wistuba; Christine M Alden; George R Blumenschein; Suzanne E Davis; Jeremy Erasmus; Frank Fossella; Sanjay Gupta; Roy S Herbst; John V Heymach; Marshall E Hicks; Bruce E Johnson; Fadlo R Khuri; Merrill S Kies; Waun K Hong
The BATTLE trial: personalizing therapy for lung cancer.
Cancer discovery 2011;1(1):44-53.
2011: Ritsuko Komaki; Zhongxing Liao; Mary Frances McAleer; Luka Milas; Michael S O'Reilly; Xiong Wei; Pamela K Allen; George R Blumenschein; Joe Y Chang; James D Cox; Melenda Jeter; Merrill S Kies
Phase I study of celecoxib with concurrent irinotecan, Cisplatin, and radiation therapy for patients with unresectable locally advanced non-small cell lung cancer.
Frontiers in oncology 2011;1():52.
2010: Adam S Garden; Merrill S Kies; Randal S Weber
To TORS or Not to TORS: but is that the question? Comment on "transoral robotic surgery for advanced oropharyngeal carcinoma".
Archives of otolaryngology--head & neck surgery 2010;136(11):1085-7.
2010: Lauren Averett Byers; F Christopher Holsinger; Merrill S Kies; William N William; Adel K El-Naggar; J Jack Lee; Jianhua Hu; Adriana Lopez; Hai T Tran; Shaoyu Yan; Zhiqiang Du; K Kian Ang; Bonnie S Glisson; Maria Gabriela Raso; Ignacio I Wistuba; Jeffrey N Myers; Waun Ki Hong; Vassiliki A Papadimitrakopoulou; Scott M Lippman; John V Heymach
Serum signature of hypoxia-regulated factors is associated with progression after induction therapy in head and neck squamous cell cancer.
Molecular cancer therapeutics 2010;9(6):1755-63.
2010: William N William; Merrill S Kies; Frank V Fossella; Diane D Liu; Gregory W Gladish; Warner H Tse; J Jack Lee; Waun K Hong; Scott M Lippman; Edward S Kim
Phase 2 study of carboplatin, docetaxel, and bevacizumab as frontline treatment for advanced nonsmall-cell lung cancer.
Cancer 2010;116(10):2401-8.
2010: Michelle D Williams; Dianna B Roberts; Merrill S Kies; Li Mao; Randal S Weber; Adel K El-Naggar
Genetic and expression analysis of HER-2 and EGFR genes in salivary duct carcinoma: empirical and therapeutic significance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2010;16(8):2266-74.
2010: Merrill S Kies; F Christopher Holsinger; J Jack Lee; William N William; Bonnie S Glisson; Heather Y Lin; Jan S Lewin; Lawrence E Ginsberg; Katharine A Gillaspy; Erminia Massarelli; Lauren Byers; Scott M Lippman; Waun K Hong; Adel K El-Naggar; Adam S Garden; Vassiliki A Papadimitrakopoulou
Induction chemotherapy and cetuximab for locally advanced squamous cell carcinoma of the head and neck: results from a phase II prospective trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2010;28(1):8-14.
2009: Emer O Hanrahan; Merrill S Kies; Bonnie S Glisson; Fadlo R Khuri; Lei Feng; Hai T Tran; Lawrence E Ginsberg; Mylene T Truong; Waun K Hong; Edward S Kim
A phase II study of Lonafarnib (SCH66336) in patients with chemorefractory, advanced squamous cell carcinoma of the head and neck.
American journal of clinical oncology 2009;32(3):274-9.
2009: Denise A Barringer; Katherine A Hutcheson; Erich M Sturgis; Merrill S Kies; Jan S Lewin
Effect of induction chemotherapy on speech and swallowing function in patients with oral tongue cancer.
Head & neck 2009;31(5):611-7.
2009: F Christopher Holsinger; Merrill S Kies; Eduardo M Diaz; Ann M Gillenwater; Jan S Lewin; Lawrence E Ginsberg; Bonnie S Glisson; Adam S Garden; Nebil Ark; Heather Y Lin; J Jack Lee; Adel K El-Naggar; Waun Ki Hong; Dong M Shin; Fadlo R Khuri
Durable long-term remission with chemotherapy alone for stage II to IV laryngeal cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(12):1976-82.
2008: David I Rosenthal; Tito R Mendoza; Mark S Chambers; V Shannon Burkett; Adam S Garden; Amy C Hessell; Jan S Lewin; K. Kian Ang; Merrill S Kies; Ibrahima Gning; Xin S Wang; Charles S Cleeland
The M. D. Anderson symptom inventory-head and neck module, a patient-reported outcome instrument, accurately predicts the severity of radiation-induced mucositis.
International journal of radiation oncology, biology, physics 2008;72(5):1355-61.
2008: Chad E Galer; Merrill S Kies
Evaluation and management of the unknown primary carcinoma of the head and neck.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(10):1068-75.
2008: David I Rosenthal; Mark S Chambers; Clifton David Fuller; Neal C S Rebueno; John Garcia; Merrill S Kies; William H Morrison; K Kian Ang; Adam S Garden
Beam path toxicities to non-target structures during intensity-modulated radiation therapy for head and neck cancer.
International journal of radiation oncology, biology, physics 2008;72(3):747-55.
2008: Ezra E W Cohen; Lee S Rosen; Everett E Vokes; Merrill S Kies; Arlene A Forastiere; Francis P Worden; Madeleine A Kane; Eric Sherman; Sinil Kim; Paul Bycott; Michael Tortorici; David R Shalinsky; Katherine F Liau; Roger B Cohen
Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2008;26(29):4708-13.
2008: Robert A Figlin; Elizabeth Brown; Andrew J Armstrong; Wallace Akerley; Al B Benson; Harold J Burstein; David S Ettinger; Phillip G Febbo; Matthew G Fury; Gary R Hudes; Merrill S Kies; Eunice L Kwak; Robert J Morgan; Joanne Mortimer; Karen Reckamp; Alan P Venook; Frank Worden; Yun Yen
NCCN Task Force Report: mTOR inhibition in solid tumors.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6 Suppl 5():S1-20; quiz S21-2.
2008: Arlene A Forastiere; Kie-Kian Ang; David Brizel; Bruce E Brockstein; Barbara A Burtness; Anthony J Cmelak; Alexander D Colevas; Frank Dunphy; David W Eisele; Helmuth Goepfert; Wesley L Hicks; Merrill S Kies; William M Lydiatt; Ellie Maghami; Renato Martins; Thomas McCaffrey; Bharat B Mittal; David G Pfister; Harlan A Pinto; Marshall R Posner; John A Ridge; Sandeep Samant; David E Schuller; Jatin P Shah; Sharon Spencer; Andy Trotti; Randal S Weber; Gregory T Wolf; Frank Worden
Head and neck cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2008;6(7):646-95.
2008: Eung Seok Lee; Jean-Pierre J Issa; Dianna B Roberts; Michelle D Williams; Randal S Weber; Merrill S Kies; Adel K El-Naggar
Quantitative promoter hypermethylation analysis of cancer-related genes in salivary gland carcinomas: comparison with methylation-specific PCR technique and clinical significance.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2664-72.
2008: George R Blumenschein; Merrill S Kies; Vassiliki A Papadimitrakopoulou; Charles Lu; Ashok J Kumar; Justin L Ricker; Judy H Chiao; Cong Chen; Stanley R Frankel
Phase II trial of the histone deacetylase inhibitor vorinostat (Zolinza, suberoylanilide hydroxamic acid, SAHA) in patients with recurrent and/or metastatic head and neck cancer.
Investigational new drugs 2008;26(1):81-7.
2008: F Christopher Holsinger; Merrill S Kies; Y Etan Weinstock; Jan S Lewin; Shaheen Hajibashi; David D Nolen; Randal Weber; Ollivier Laccourreye
Videos in clinical medicine. Examination of the larynx and pharynx.
The New England journal of medicine 2008;358(3):e2.
2007: Michelle D Williams; Dianna Roberts; George R Blumenschein; Stéphane Temam; Merrill S Kies; David I Rosenthal; Randal S Weber; Adel K El-Naggar
Differential expression of hormonal and growth factor receptors in salivary duct carcinomas: biologic significance and potential role in therapeutic stratification of patients.
The American journal of surgical pathology 2007;31(11):1645-52.
2007: David I Rosenthal; Tito R Mendoza; Mark S Chambers; Joshua A Asper; Ibrahima Gning; Merrill S Kies; Randal S Weber; Jan S Lewin; Adam S Garden; K. Kian Ang; Xin S Wang; Charles S Cleeland
Measuring head and neck cancer symptom burden: the development and validation of the M. D. Anderson symptom inventory, head and neck module.
Head & neck 2007;29(10):923-31.
2007: Merrill S Kies
Induction chemotherapy for head and neck squamous cell carcinomas (SCCHN).
Current treatment options in oncology 2007;8(3):252-60.
2007: Desmond Curran; Jordi Giralt; Paul M Harari; K. Kian Ang; Roger B Cohen; Merrill S Kies; Jacek Jassem; José Baselga; Eric K Rowinsky; Nadia Amellal; Sylvie Comte; James A. Bonner
Quality of life in head and neck cancer patients after treatment with high-dose radiotherapy alone or in combination with cetuximab.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(16):2191-7.
2007: Merrill S Kies
Induction chemotherapy for squamous cancer of the head and neck.
Current oncology reports 2007;9(2):129-33.
2007: Jason W Nash; Terry L Barrett; Merrill S Kies; Merrick I Ross; Nour Sneige; A Hafeez Diwan; Alexander Lazar
Metastatic hidradenocarcinoma with demonstration of Her-2/neu gene amplification by fluorescence in situ hybridization: potential treatment implications.
Journal of cutaneous pathology 2007;34(1):49-54.
2006: Michelle D Williams; Nitin Chakravarti; Merrill S Kies; Shin-ichiro Maruya; Jeffrey N Myers; Joie C Haviland; Randal S Weber; Reuben Lotan; Adel K El-Naggar
Implications of methylation patterns of cancer genes in salivary gland tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(24):7353-8.
2006: Bita Esmaeli; Dominick Golio; Merrill S Kies; Franco DeMonte
Surgical management of locally advanced adenoid cystic carcinoma of the lacrimal gland.
Ophthalmic plastic and reconstructive surgery 2006;22(5):366-70.
2006: Anne S Tsao; Adam S Garden; Merrill S Kies; William Morrison; Lei Feng; J Jack Lee; Fadlo R Khuri; Ralph G Zinner; Jeffery Myers; Vassiliki A Papadimitrakopoulou; Jan Lewin; Gary L Clayman; K. Kian Ang; Bonnie S Glisson
Phase I/II study of docetaxel, cisplatin, and concomitant boost radiation for locally advanced squamous cell cancer of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4163-9.
2006: Michael A Carducci; Luna Musib; Merrill S Kies; Roberto Pili; Mylene Truong; Julie R Brahmer; Patricia Cole; Rana Sullivan; Jeanne Riddle; Jill Schmidt; Nathan Enas; Vikram Sinha; Donald E Thornton; Roy S Herbst
Phase I dose escalation and pharmacokinetic study of enzastaurin, an oral protein kinase C beta inhibitor, in patients with advanced cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(25):4092-9.
2006: Ezra E W Cohen; Daniel J Haraf; Marcy A List; Masha Kocherginsky; Bharat B Mittal; Fred R Rosen; Bruce E Brockstein; Rosalyn Williams; Mary Ellyn Witt; Kerstin M Stenson; Merrill S Kies; Everett E Vokes
High survival and organ function rates after primary chemoradiotherapy for intermediate-stage squamous cell carcinoma of the head and neck treated in a multicenter phase II trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2006;24(21):3438-44.
2006: Sue S Yom; David I Rosenthal; Adel K El-Naggar; Merrill S Kies; Amy C Hessel
Merkel cell carcinoma of the tongue and head and neck oral mucosal sites.
Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics 2006;101(6):761-8.
2006: Sheeba K Thomas; Frank V Fossella; Diane Liu; Rainell Schaerer; Anne S Tsao; Merrill S Kies; Katherine M W Pisters; George R Blumenschein; Bonnie S Glisson; J Jack Lee; Roy S Herbst; Ralph G Zinner
Asian ethnicity as a predictor of response in patients with non-small-cell lung cancer treated with gefitinib on an expanded access program.
Clinical lung cancer 2006;7(5):326-31.
2006: Jill Gilbert; Yi Li; Harlan A Pinto; Timothy Jennings; Merrill S Kies; Paula Silverman; Arlene A Forastiere
Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.
Head & neck 2006;28(3):197-204.
2006: James A. Bonner; Paul M Harari; Jordi Giralt; Nozar Azarnia; Dong M Shin; Roger B Cohen; Christopher U Jones; Ranjan Sur; David Raben; Jacek Jassem; Roger Ove; Merrill S Kies; Jose Baselga; Hagop Youssoufian; Nadia Amellal; Eric K Rowinsky; K. Kian Ang
Radiotherapy plus cetuximab for squamous-cell carcinoma of the head and neck.
The New England journal of medicine 2006;354(6):567-78.
2006: Seung-Hyun Oh; Woo-Young Kim; Jai-Hyun Kim; Maher N Younes; Adel K El-Naggar; Jeffrey N Myers; Merrill S Kies; Pinchas Cohen; Fadlo R Khuri; Waun Ki Hong; Ho-Young Lee
Identification of insulin-like growth factor binding protein-3 as a farnesyl transferase inhibitor SCH66336-induced negative regulator of angiogenesis in head and neck squamous cell carcinoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(2):653-61.
2005: Randal S Weber; Merrill S Kies; David I Rosenthal
Postoperative treatment intensification for improving outcome in the high-risk patient: an evolutionary process.
Head & neck 2005;27(10):841-2.
2005: Erich M Sturgis; Brian A Moore; Bonnie S Glisson; Merrill S Kies; Dong M Shin; Robert M Byers
Neoadjuvant chemotherapy for squamous cell carcinoma of the oral tongue in young adults: a case series.
Head & neck 2005;27(9):748-56.
2005: Hope S Rugo; Roy S Herbst; Glenn Liu; John W Park; Merrill S Kies; Heidi M Steinfeldt; Yazdi K Pithavala; Steven D Reich; James L Freddo; George Wilding
Phase I trial of the oral antiangiogenesis agent AG-013736 in patients with advanced solid tumors: pharmacokinetic and clinical results.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5474-83.
2005: Roy S Herbst; Matthew A Arquette; Dong M Shin; Karel Dicke; Everett E Vokes; Nozar Azarnia; Waun Ki Hong; Merrill S Kies
Phase II multicenter study of the epidermal growth factor receptor antibody cetuximab and cisplatin for recurrent and refractory squamous cell carcinoma of the head and neck.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(24):5578-87.
2005: Edward S Kim; Merrill S Kies; Frank V Fossella; Bonnie S Glisson; Sara Zaknoen; Paul Statkevich; Reginald F Munden; Carmen Summey; Katherine M W Pisters; Vassiliki A Papadimitrakopoulou; Mourad Tighiouart; André Rogatko; Fadlo R Khuri
Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane-refractory/resistant nonsmall cell lung carcinoma.
Cancer 2005;104(3):561-9.
2005: Shin-ichiro Maruya; Merrill S Kies; Michelle Williams; Jeffrey N Myers; Randal S Weber; John G Batsakis; Adel K El-Naggar
Differential expression of p63 isotypes (DeltaN and TA) in salivary gland neoplasms: biological and diagnostic implications.
Human pathology 2005;36(7):821-7.
2005: Ratna K Vadlamudi; Seetharaman Balasenthil; Aysegul A Sahin; Merrill S Kies; Randal S Weber; Rakesh Kumar; Adel K El-Naggar
Novel estrogen receptor coactivator PELP1/MNAR gene and ERbeta expression in salivary duct adenocarcinoma: potential therapeutic targets.
Human pathology 2005;36(6):670-5.
2005: Vassiliki A Papadimitrakopoulou; Sofia Agelaki; Hai T Tran; Merrill S Kies; Robert Gagel; Ralph G Zinner; Edward Kim; Gregory D Ayers; John Wright; Fadlo R Khuri
Phase I study of the farnesyltransferase inhibitor BMS-214662 given weekly in patients with solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(11):4151-9.
2005: Arlene A Forastiere; K. Kian Ang; David M. Brizel; Bruce Earl Brockstein; Frank Dunphy; David W Eisele; Helmuth Goepfert; Wesley L Hicks; Merrill S Kies; William M Lydiatt; Ellie Maghami; Thomas McCaffrey; Bharat B Mittal; David G Pfister; Harlan A Pinto; Marshall R Posner; John A Ridge; Samant Sandeep; David E Schuller; Jatin P Shah; Sharon Spencer; Andrew Trotti; Richard H Wheeler; Gregory T Wolf; Francis P Worden; Bevan Yueh
Head and neck cancers.
Journal of the National Comprehensive Cancer Network : JNCCN 2005;3(3):316-91.
2005: Zhongxing Liao; Ritsuko Komaki; Luka Milas; Chen Yuan; Merrill S Kies; Joe Y Chang; Melenda Jeter; Thomas Guerrero; George Blumenschien; Cheryl M Smith; Frank V Fossella; Barry Brown; James D Cox
A phase I clinical trial of thoracic radiotherapy and concurrent celecoxib for patients with unfavorable performance status inoperable/unresectable non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(9):3342-8.
2005: Merrill S Kies
New treatments in head and neck cancer.
Clinical advances in hematology & oncology : H&O 2005;3(2):92-3.
2004: David I Rosenthal; Jerry L Barker; Adel K El-Naggar; Bonnie S Glisson; Merrill S Kies; Eduardo M Diaz; Gary L Clayman; Franco DeMonte; Ugur Selek; William H Morrison; K. Kian Ang; K.S. Chao; Adam S Garden
Sinonasal malignancies with neuroendocrine differentiation: patterns of failure according to histologic phenotype.
Cancer 2004;101(11):2567-73.
2004: Merrill S Kies
Head and neck cancer: integrating anti-EGFR treatment with standard therapy.
Journal of the National Comprehensive Cancer Network : JNCCN 2004;2 Suppl 2():S52-9.
2004: Mark S Chambers; Adam S Garden; Merrill S Kies; Jack W Martin
Radiation-induced xerostomia in patients with head and neck cancer: pathogenesis, impact on quality of life, and management.
Head & neck 2004;26(9):796-807.
2004: Bruce E Brockstein; Daniel J Haraf; Alfred W Rademaker; Merrill S Kies; Kerstin M Stenson; Fred R Rosen; Bharat B Mittal; Harold Pelzer; B B Fung; Mary Ellyn Witt; Barry L Wenig; Louis Portugal; R W Weichselbaum; Everett E Vokes
Patterns of failure, prognostic factors and survival in locoregionally advanced head and neck cancer treated with concomitant chemoradiotherapy: a 9-year, 337-patient, multi-institutional experience.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2004;15(8):1179-86.
2004: Shin-ichiro Maruya; Hyung Woo Kim; Randal S Weber; Jack J Lee; Merrill S Kies; Mario A Luna; John G Batsakis; Adel K El-Naggar
Gene expression screening of salivary gland neoplasms: molecular markers of potential histogenetic and clinical significance.
The Journal of molecular diagnostics : JMD 2004;6(3):180-90.
2004: Fadlo R Khuri; Bonnie S Glisson; Edward S Kim; Paul Statkevich; Peter F Thall; Michael L Meyers; Roy S Herbst; Reginald F Munden; Craig Tendler; Yali Zhu; Sandra Bangert; Elizabeth Thompson; Charles Lu; Xue-Mei Wang; Dong M Shin; Merrill S Kies; Vassiliki A Papadimitrakopoulou; Frank V Fossella; Paul Kirschmeier; W Robert Bishop; Waun Ki Hong
Phase I study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in solid tumors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(9):2968-76.
2004: Athanassios Argiris; Kerstin M Stenson; Bruce E Brockstein; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Prathima Jayaram; Louis Portugal; Barry L Wenig; Fred R Rosen; Daniel J Haraf; Everett E Vokes
Neck dissection in the combined-modality therapy of patients with locoregionally advanced head and neck cancer.
Head & neck 2004;26(5):447-55.
2004: Ritsuko Komaki; Jin Soo Lee; Luka Milas; Hoon K Lee; Frank V Fossella; Roy S Herbst; Pamela K Allen; Zhongxing Liao; Craig W Stevens; Charles Lu; Ralph G Zinner; Vassiliki A Papadimitrakopoulou; Merrill S Kies; George R Blumenschein; Katherine M W Pisters; Bonnie S Glisson; Jonathan M Kurie; Bunyamin Kaplan; Veronica P Garza; Deidre Mooring; Susan L Tucker; James D Cox
Effects of amifostine on acute toxicity from concurrent chemotherapy and radiotherapy for inoperable non-small-cell lung cancer: report of a randomized comparative trial.
International journal of radiation oncology, biology, physics 2004;58(5):1369-77.
2004: Ralph G Zinner; Bonnie S Glisson; Frank V Fossella; Katherine M W Pisters; Merrill S Kies; Pamela M Lee; Erminia Massarelli; Bradley Sabloff; Herbert A Fritsche; Jae Y Ro; Nelson G Ordonez; Hai T Tran; Ying Yang; Terry L Smith; Robert D Mass; Roy S Herbst
Trastuzumab in combination with cisplatin and gemcitabine in patients with Her2-overexpressing, untreated, advanced non-small cell lung cancer: report of a phase II trial and findings regarding optimal identification of patients with Her2-overexpressing disease.
Lung cancer (Amsterdam, Netherlands) 2004;44(1):99-110.
2004: Athanassios Argiris; Bruce E Brockstein; Daniel J Haraf; Kerstin M Stenson; Bharat B Mittal; Merrill S Kies; Fred R Rosen; Borko Jovanovic; Everett E Vokes
Competing causes of death and second primary tumors in patients with locoregionally advanced head and neck cancer treated with chemoradiotherapy.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(6):1956-62.
2004: Adam S Garden; Joshua A Asper; William H Morrison; Naomi R Schechter; Bonnie S Glisson; Merrill S Kies; Jeffrey N Myers; K. Kian Ang
Is concurrent chemoradiation the treatment of choice for all patients with Stage III or IV head and neck carcinoma?
Cancer 2004;100(6):1171-8.
2004: Faye M Johnson; Adam Garden; J Lynn Palmer; Merrill S Kies; Gary L Clayman; Brenda Brumfield; Fadlo R Khuri; William Morrison; Vassiliki A Papadimitrakopoulou; Eduardo M Diaz; Bonnie S Glisson
A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N status.
Cancer 2004;100(5):991-8.
2004: Edward S Kim; Everett E Vokes; Merrill S Kies
Cetuximab in cancers of the lung and head & neck.
Seminars in oncology 2004;31(1 Suppl 1):61-7.
2004: Bonnie S Glisson; A Dimitrios Colevas; Robert I Haddad; Jeffrey F Krane; Adel El-Naggar; Merrill S Kies; Rosemary Costello; Carmen Summey; Matthew A Arquette; Corey Langer; Philip C Amrein; Marshall R Posner
HER2 expression in salivary gland carcinomas: dependence on histological subtype.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(3):944-6.
2004: Marcy A List; Judith Lee Rutherford; John Stracks; Barbara Roa Pauloski; Jeri A Logemann; Donna S Lundy; Paula Sullivan; W Jarrard Goodwin; Merrill S Kies; Everett E Vokes
Prioritizing treatment outcomes: head and neck cancer patients versus nonpatients.
Head & neck 2004;26(2):163-70.
2004: Bita Esmaeli; M Amir Ahmadi; Adel Youssef; Roxana Diba; Malena Amato; Jeffrey N Myers; Merrill S Kies; Adel El-Naggar
Outcomes in patients with adenoid cystic carcinoma of the lacrimal gland.
Ophthalmic plastic and reconstructive surgery 2004;20(1):22-6.
2003: Vassiliki A Papadimitrakopoulou; Lawrence E Ginsberg; Adam S Garden; Merrill S Kies; Bonnie S Glisson; Eduardo M Diaz; Gary L Clayman; William H Morrison; Diane D Liu; George R Blumenschein; Scott M Lippman; Donald Schommer; Ann M Gillenwater; Helmuth Goepfert; Waun Ki Hong
Intraarterial cisplatin with intravenous paclitaxel and ifosfamide as an organ-preservation approach in patients with paranasal sinus carcinoma.
Cancer 2003;98(10):2214-23.
2003: Roy S Herbst; Merrill S Kies
Gefitinib: current and future status in cancer therapy.
Clinical advances in hematology & oncology : H&O 2003;1(8):466-72.
2003: Athanassios Argiris; S M Smith; Kerstin M Stenson; Bharat B Mittal; Harold Pelzer; Merrill S Kies; Daniel J Haraf; E E Vokes
Concurrent chemoradiotherapy for N2 or N3 squamous cell carcinoma of the head and neck from an occult primary.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(8):1306-11.
2003: Fred R Rosen; Daniel J Haraf; Merrill S Kies; Kerstin M Stenson; Louis Portugal; Marcy A List; Bruce E Brockstein; Bharat B Mittal; Alfred W Rademaker; Mary Ellyn Witt; Harold Pelzer; Ralph R Weichselbaum; Everett E Vokes
Multicenter randomized Phase II study of paclitaxel (1-hour infusion), fluorouracil, hydroxyurea, and concomitant twice daily radiation with or without erythropoietin for advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2003;9(5):1689-97.
2003: J L Oh; Everett E Vokes; Merrill S Kies; Bharat B Mittal; Mary Ellyn Witt; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced nasopharyngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2003;14(4):564-9.
2003: Gregory A Masters; Elizabeth A Hahn; Daniel H Shevrin; Merrill S Kies
Phase I/II trial of vinorelbine and divided-dose carboplatin in advanced non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2003;39(2):221-6.
2003: Everett E Vokes; Kerstin M Stenson; Fred R Rosen; Merrill S Kies; Alfred W Rademaker; Mary Ellyn Witt; Bruce E Brockstein; Marcy A List; Bing Bing Fung; Louis Portugal; Bharat B Mittal; Harold Pelzer; Ralph R Weichselbaum; Daniel J Haraf
Weekly carboplatin and paclitaxel followed by concomitant paclitaxel, fluorouracil, and hydroxyurea chemoradiotherapy: curative and organ-preserving therapy for advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2003;21(2):320-6.
2003: Athanassios Argiris; Daniel J Haraf; Merrill S Kies; Everett E Vokes
Intensive concurrent chemoradiotherapy for head and neck cancer with 5-Fluorouracil- and hydroxyurea-based regimens: reversing a pattern of failure.
The oncologist 2003;8(4):350-60.
2002: Mark A Socinski; Michael J Schell; Kamal Bakri; Amy Peterman; Ji-Hyun Lee; Paul Unger; Steven Yates; Stacie A Hudgens; Merrill S Kies
Second-line, low-dose, weekly paclitaxel in patients with stage IIIB/IV nonsmall cell lung carcinoma who fail first-line chemotherapy with carboplatin plus paclitaxel.
Cancer 2002;95(6):1265-73.
2002: Roy S Herbst; Fadlo R Khuri; Charles Lu; Diane D Liu; Frank V Fossella; Bonnie S Glisson; Katherine M W Pisters; Dong M Shin; Vassiliki A Papadimitrakopoulou; Jonathan M Kurie; George R Blumenschein; Merrill S Kies; Ralph G Zinner; Maria S Jung; Robert Lu; J Jack Lee; Reginald F Munden; Waun Ki Hong; Jin Soo Lee
The novel and effective nonplatinum, nontaxane combination of gemcitabine and vinorelbine in advanced nonsmall cell lung carcinoma: potential for decreased toxicity and combination with biological therapy.
Cancer 2002;95(2):340-53.
2002: Dong M Shin; Bonnie S Glisson; Fadlo R Khuri; Scott M Lippman; Lawrence E Ginsberg; Edward Diaz; Vassiliki A Papadimitrakopoulou; Lei Feng; Marites Francisco; Adam Garden; Merrill S Kies; Jeffrey L Myers; Gary L Clayman; Waun Ki Hong
Phase II study of induction chemotherapy with paclitaxel, ifosfamide, and carboplatin (TIC) for patients with locally advanced squamous cell carcinoma of the head and neck.
Cancer 2002;95(2):322-30.
2002: Merrill S Kies; Paul M Harari
Cetuximab (Imclone/Merck/Bristol-Myers Squibb).
Current opinion in investigational drugs (London, England : 2000) 2002;3(7):1092-100.
2002: Marcy A List; Judith Lee Rutherford; John Stracks; Daniel J Haraf; Merrill S Kies; Everett E Vokes
An exploration of the pretreatment coping strategies of patients with carcinoma of the head and neck.
Cancer 2002;95(1):98-104.
2002: Edward S Kim; Merrill S Kies; Roy S Herbst
Novel therapeutics for head and neck cancer.
Current opinion in oncology 2002;14(3):334-42.
2002: Mark A Socinski; Michael J Schell; Amy Peterman; Kamal Bakri; Steven Yates; Robert Gitten; Paul Unger; Joanna Lee; Ji-Hyun Lee; Maureen Tynan; Martha Moore; Merrill S Kies
Phase III trial comparing a defined duration of therapy versus continuous therapy followed by second-line therapy in advanced-stage IIIB/IV non-small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2002;20(5):1335-43.
2002: Roy S Herbst; Merrill S Kies
ZD1839 (Iressa) in non-small cell lung cancer.
The oncologist 2002;7 Suppl 4():9-15.
2002: Timothy M Kuzel; Merrill S Kies; Nini Wu; Yi-Ching Hsieh; Alfred W Rademaker
Phase I trial of oral estramustine and 3-hr infusional paclitaxel for the treatment of hormone refractory prostate cancer.
Cancer investigation 2002;20(5-6):634-43.
2001: Eduardo M Diaz; Merrill S Kies
Chemotherapy for skull base cancers.
Otolaryngologic clinics of North America 2001;34(6):1079-85, viii.
2001: Roy S Herbst; Fadlo R Khuri; Frank V Fossella; Bonnie S Glisson; Merrill S Kies; Katherine M W Pisters; Jeanne Riddle; K A Terry; J S Lee
ZD1839 (Iressa) in non-small-cell lung cancer.
Clinical lung cancer 2001;3(1):27-32.
2001: Merrill S Kies; Daniel J Haraf; Fred R Rosen; Kerstin M Stenson; Marcy A List; Bruce E Brockstein; T Chung; Bharat B Mittal; Harold Pelzer; Louis Portugal; Alfred Rademaker; R Weichselbaum; Everett E Vokes
Concomitant infusional paclitaxel and fluorouracil, oral hydroxyurea, and hyperfractionated radiation for locally advanced squamous head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2001;19(7):1961-9.
2001: CA Mantz; Everett E Vokes; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Sequential induction chemotherapy and concomitant chemoradiotherapy in the management of locoregionally advanced laryngeal cancer.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2001;12(3):343-7.
2001: CA Mantz; Everett E Vokes; Kerstin M Stenson; Merrill S Kies; B Mittal; Mary Ellyn Witt; Marcy A List; Ralph R Weichselbaum; Daniel J Haraf
Induction chemotherapy followed by concomitant chemoradiotherapy in the treatment of locoregionally advanced oropharyngeal cancer.
Cancer journal (Sudbury, Mass.) 2001;7(2):140-8.
2001: Merrill S Kies; Charles L Bennett; Everett E Vokes
Locally advanced head and neck cancer.
Current treatment options in oncology 2001;2(1):7-13.
2000: Everett E Vokes; Daniel J Haraf; Merrill S Kies
The use of concurrent chemotherapy and radiotherapy for locoregionally advanced head and neck cancer.
Seminars in oncology 2000;27(4 Suppl 8):34-8.
2000: Kerstin M Stenson; Daniel J Haraf; Harold Pelzer; Wendy Recant; Merrill S Kies; Ralph R Weichselbaum; Everett E Vokes
The role of cervical lymphadenectomy after aggressive concomitant chemoradiotherapy: the feasibility of selective neck dissection.
Archives of otolaryngology--head & neck surgery 2000;126(8):950-6.
2000: Mark W Lingen; Kuo-Wei Chang; S J McMurray; Dennis B Solt; Merrill S Kies; Bharat B Mittal; G Kenneth Haines; Harold Pelzer
Overexpression of p53 in squamous cell carcinoma of the tongue in young patients with no known risk factors is not associated with mutations in exons 5-9.
Head & neck 2000;22(4):328-35.
2000: Everett E Vokes; Merrill S Kies; Daniel J Haraf; Kerstin M Stenson; Marcy A List; Rod A Humerickhouse; M Eileen Dolan; Harold Pelzer; L Sulzen; Mary Ellyn Witt; Y C Hsieh; Bharat B Mittal; Ralph R Weichselbaum
Concomitant chemoradiotherapy as primary therapy for locoregionally advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(8):1652-61.
2000: Marcy A List; John Stracks; Linda H Colangelo; P Butler; N Ganzenko; Donna S Lundy; P Sullivan; Daniel J Haraf; Merrill S Kies; W Jarrard Goodwin; Everett E Vokes
How Do head and neck cancer patients prioritize treatment outcomes before initiating treatment?
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2000;18(4):877-84.
1999: Marcy A List; Amy K Siston; Daniel J Haraf; Phil L Schumm; Merrill S Kies; Kerstin M Stenson; Everett E Vokes
Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(3):1020-8.
1999: Daniel J Haraf; Merrill S Kies; Alfred W Rademaker; Kerstin M Stenson; B Mittal; Harold Pelzer; Barry L Wenig; Mary Ellyn Witt; L Sulzen; Ralph R Weichselbaum; Everett E Vokes
Radiation therapy with concomitant hydroxyurea and fluorouracil in stage II and III head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(2):638-44.
1999: Rod A Humerickhouse; M Eileen Dolan; Daniel J Haraf; Bruce E Brockstein; Kerstin M Stenson; Merrill S Kies; L Sulzen; Mark J Ratain; Everett E Vokes
Phase I study of eniluracil, a dihydropyrimidine dehydrogenase inactivator, and oral 5-fluorouracil with radiation therapy in patients with recurrent or advanced head and neck cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(2):291-8.
1998: Merrill S Kies; Daniel J Haraf; I Athanasiadis; Mark F. Kozloff; B Mittal; Harold Pelzer; Alfred W Rademaker; Barry L Wenig; Ralph R Weichselbaum; Everett E Vokes
Induction chemotherapy followed by concurrent chemoradiation for advanced head and neck cancer: improved disease control and survival.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1998;16(8):2715-21.
1997: I Athanasiadis; S Taylor; Everett E Vokes; Harold Pelzer; Alfred Rademaker; Bharat B Mittal; N Ganzenko; R Blough; E P Lester; Merrill S Kies
Phase II study of induction and adjuvant chemotherapy for squamous cell carcinoma of the head and neck. A long-term analysis for the Illinois Cancer Center.
Cancer 1997;79(3):588-94.
1996: Everett E Vokes; R Mick; Merrill S Kies; M Eileen Dolan; D Malone; I Athanasiadis; Daniel J Haraf; Mark F. Kozloff; Ralph R Weichselbaum; Mark J Ratain
Pharmacodynamics of fluorouracil-based induction chemotherapy in advanced head and neck cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(5):1663-71.
1995: I Athanasiadis; Merrill S Kies; M Miller; N Ganzenko; A Joob; M Marymont; A Rademaker; W J Gradishar
Phase II study of all-trans-retinoic acid and alpha-interferon in patients with advanced non-small cell lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1995;1(9):973-9.
1995: Everett E Vokes; Merrill S Kies; Daniel J Haraf; R Mick; W J Moran; Mark F. Kozloff; B Mittal; Harold Pelzer; Barry L Wenig; WR Panje
Induction chemotherapy followed by concomitant chemoradiotherapy for advanced head and neck cancer: impact on the natural history of the disease.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1995;13(4):876-83.
1995: F Rosen; Everett E Vokes; T Lad; Merrill S Kies; James L Wade Iii; L J Kilton; R Blough; S French; M Mullane; Al B Benson
Phase II study of amonafide in the treatment of patients with advanced squamous cell carcinoma of the head and the neck. An Illinois Cancer Center study.
Investigational new drugs 1995;13(3):249-52.
1994: Merrill S Kies; D Grinblatt; Melissa Runge-Morris; R Blough; A Watkins; S Taylor
Phase II study of intravenous melphalan (NSC-8806) in the treatment of patients with advanced squamous carcinoma of the head and neck.
Investigational new drugs 1994;12(1):45-7.
1990: B B Mittal; V Sathiaseelan; Merrill S Kies
Simultaneous localized 915 MHz external and interstitial microwave hyperthermia to heat tumors greater than 3 cm in depth.
International journal of radiation oncology, biology, physics 1990;19(3):669-75.
1990: W J Gradishar; Everett E Vokes; Merrill S Kies
Phase II trial of etoposide and doxorubicin in advanced head and neck cancer.
Medical and pediatric oncology 1990;18(6):487-90.
1989: Melissa Runge-Morris; Merrill S Kies; Everett E Vokes; R Blough; L Weidner; R Knop; K Rowland
Evaluation of homoharringtonine efficacy in the treatment of squamous cell carcinoma of the head and neck: a phase II Illinois Cancer Council Study.
Investigational new drugs 1989;7(2-3):269-73.
1987: Merrill S Kies; Steven T Rosen; T K Tsang; R Shetty; P A Schneider; C B Wallemark; T W Shields
Cisplatin and 5-fluorouracil in the primary management of squamous esophageal cancer.
Cancer 1987;60(9):2156-60.
1985: D L Citrin; Merrill S Kies; C B Wallemark; J Khandekar; E Kaplan; F Camacho; R Lind
A phase II study of high-dose estrogens (diethylstilbestrol diphosphate) in prostate cancer.
Cancer 1985;56(3):457-60.
1984: D L Citrin; P Elson; Merrill S Kies; R Lind
Decreased serum phosphate levels after high-dose estrogens in metastatic prostate cancer. Possible implications.
The American journal of medicine 1984;76(5):787-93.